Skip to main content
Caplight Logo









MyMeds

MyMeds

Private
Minneapolis, MinnesotaHealthcare & Life Scienceshttps://my-meds.com

Last Round

VC Round

Mar 10, 2020

Company Overview

MyMeds operates in Healthcare & Life Sciences and is based in Minneapolis, Minnesota. Its latest recorded funding round was a VC Round in March 2020.

MyMeds is a healthtech company that provides a digital medication management and analytics platform designed to improve medication adherence and support value-based care initiatives.

Sector

Healthcare & Life Sciences

Verticals

Healthcare Analytics, Patient Engagement, Data Integration, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

MyMeds Comparables

Compare MyMeds with similar companies based on industry and business-model similarity.

MyMeds comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Arine
80%
RxAnte
80%
AdhereHealth
78%
Book a demo to see all comparables

For institutional investors. Book with your work email.

MyMeds Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMar 10, 2020
AcceleratorSep 4, 2019
Convertible DebtAug 13, 2018
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

MyMeds Investors

Notable investors and investment history

MyMeds investors
InvestorRounds
Seae VenturesConvertible Debt
Artifact CapitalConvertible Debt
SAP.iO FoundryConvertible Debt, Accelerator
SAP.iOAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 16, 2026

    Monthly visitors grew 339% MoM, reaching 7K.

  • Sep 4, 2019

    Received funding from SAP.iO and SAP.iO Foundry.

Book a demo to see all signals

For institutional investors. Book with your work email.

MyMeds Filings

Explore SEC and related filing metadata, where available.

MyMeds filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about MyMeds's valuation, stock price, and market status.

Is MyMeds a public or private company?

MyMeds is a private company.

What is the current stock price of MyMeds?

MyMeds is a private company, so its shares have no public market price. Caplight tracks MyMeds's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is MyMeds worth (valuation)?

Valuation information for MyMeds is not publicly available.

Can I buy MyMeds stock?

MyMeds shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was MyMeds's last funding round?

MyMeds's most recent funding round was VC Round on March 10, 2020.

Who are the main investors in MyMeds?

Key investors in MyMeds include SAP.iO.

Will MyMeds IPO soon?

No public IPO plans have been announced for MyMeds.

How can I track MyMeds secondary market activity?

Caplight tracks bids, offers, and trades in MyMeds's shares on secondary markets.

Firmographic Details

HeadquartersMinneapolis, Minnesota
Employee Range15
Year Founded2013
Last FundingMar 10, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?